These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16689670)

  • 1. Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats.
    Tamás A; Zsombok A; Farkas O; Reglödi D; Pál J; Büki A; Lengvári I; Povlishock JT; Dóczi T
    J Neurotrauma; 2006 May; 23(5):686-95. PubMed ID: 16689670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.
    Farkas O; Tamás A; Zsombok A; Reglodi D; Pál J; Büki A; Lengvári I; Povlishock JT; Dóczi T
    Regul Pept; 2004 Dec; 123(1-3):69-75. PubMed ID: 15518895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttraumatic administration of pituitary adenylate cyclase activating polypeptide in central fluid percussion injury in rats.
    Kövesdi E; Tamás A; Reglodi D; Farkas O; Pál J; Tóth G; Bukovics P; Dóczi T; Büki A
    Neurotox Res; 2008 Apr; 13(2):71-8. PubMed ID: 18515209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4/MyD88/NF-κB pathway.
    Mao SS; Hua R; Zhao XP; Qin X; Sun ZQ; Zhang Y; Wu YQ; Jia MX; Cao JL; Zhang YM
    J Neurotrauma; 2012 Jul; 29(10):1941-59. PubMed ID: 22583372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury.
    Buki A; Farkas O; Doczi T; Povlishock JT
    J Neurotrauma; 2003 Mar; 20(3):261-8. PubMed ID: 12820680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid Beta peptide in traumatic axonal injury.
    Stone JR; Okonkwo DO; Singleton RH; Mutlu LK; Helm GA; Povlishock JT
    J Neurotrauma; 2002 May; 19(5):601-14. PubMed ID: 12042095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury.
    Büki A; Okonkwo DO; Povlishock JT
    J Neurotrauma; 1999 Jun; 16(6):511-21. PubMed ID: 10391367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the relationship between intra- axonal neurofilament compaction and impaired axonal transport following diffuse traumatic brain injury.
    Marmarou CR; Walker SA; Davis CL; Povlishock JT
    J Neurotrauma; 2005 Oct; 22(10):1066-80. PubMed ID: 16238484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats.
    Thornton E; Vink R; Blumbergs PC; Van Den Heuvel C
    Brain Res; 2006 Jun; 1094(1):38-46. PubMed ID: 16697978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury.
    Marmarou CR; Povlishock JT
    Exp Neurol; 2006 Feb; 197(2):353-62. PubMed ID: 16297913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttraumatic hypothermia in the treatment of axonal damage in an animal model of traumatic axonal injury.
    Koizumi H; Povlishock JT
    J Neurosurg; 1998 Aug; 89(2):303-9. PubMed ID: 9688127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of traumatically induced axonal injury by rapid posthypothermic rewarming and attenuation of axonal change by cyclosporin A.
    Suehiro E; Povlishock JT
    J Neurosurg; 2001 Mar; 94(3):493-8. PubMed ID: 11235956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model.
    Mills JD; Bailes JE; Sedney CL; Hutchins H; Sears B
    J Neurosurg; 2011 Jan; 114(1):77-84. PubMed ID: 20635852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury.
    Stone JR; Okonkwo DO; Dialo AO; Rubin DG; Mutlu LK; Povlishock JT; Helm GA
    Exp Neurol; 2004 Nov; 190(1):59-69. PubMed ID: 15473980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury.
    Singleton RH; Stone JR; Okonkwo DO; Pellicane AJ; Povlishock JT
    J Neurotrauma; 2001 Jun; 18(6):607-14. PubMed ID: 11437083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats.
    O'Connor CA; Cernak I; Johnson F; Vink R
    Exp Neurol; 2007 May; 205(1):145-53. PubMed ID: 17362936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans.
    van Landeghem FK; Weiss T; Oehmichen M; von Deimling A
    Acta Neuropathol; 2007 Jun; 113(6):683-93. PubMed ID: 17431645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-traumatic hypoxia exacerbates brain tissue damage: analysis of axonal injury and glial responses.
    Hellewell SC; Yan EB; Agyapomaa DA; Bye N; Morganti-Kossmann MC
    J Neurotrauma; 2010 Nov; 27(11):1997-2010. PubMed ID: 20822466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.